• Duke Genome Institute at Hazard

    Duke Check | The Duke Genome Institute may be in peril after a ten-year review, as insiders suggest the Institute will be dismantled and its members relegated to separate departments of the university.

    Nov 27, 2013

  • Room on Campus for Big Data

    Bio-IT World | The Moore and Sloan Foundations are providing a $40 million grant to build university spaces for data science.

    Nov 26, 2013

  • De Novo Protein Modeling With X-ray Lasers

    Bio-IT World News Brief | Using the well-studied enzyme lysozyme as a proof-of-concept, researchers at Stanford's SLAC National Accelerator Laboratory have demonstrated that X-ray laser technology can generate 3D models of unknown proteins without any prior knowledge of their structure.

    Nov 25, 2013

  • FDA to 23andMe: Stop Marketing Kits Immediately

    Bio-IT World | The Food and Drug Administration issued a warning letter to 23andMe CEO Anne Wojcicki on Friday, demanding that the company "immediately discontinue marketing the [Personal Genome Service]."

    Nov 25, 2013

  • Oxford Nanopore Calls for Early Access Program Applicants

    Bio-IT World News Brief | Oxford Nanopore this morning invited registration for the MinION Access Programme (MAP). Registration will remain open through the holiday period, the company said. In early 2014, at least two days notice will be given of closure of the registration period. Preference will not be given to early applicants.

    Nov 25, 2013

  • The Druggable Genome Is Now Googleable

    Bio-IT World | Twin brothers Obi and Malachi Griffith have developed a free online database, the Drug Gene Interaction Database at dgidb.org, where researchers can quickly sort through the known drug interactions in the human genome.

    Nov 22, 2013

  • CLC bio Stays the Course

    Bio-IT World | CLC bio, the world’s largest software developer for first-tier analysis of raw sequencing data, was recently acquired by QIAGEN and swept into a sequencing-to-informatics pipeline built around the still-unreleased GeneReader instrument. Big changes for this industry leader? Perhaps not.

    Nov 20, 2013

  • Frederick Sanger Dies, 95

    BBC | Frederick Sanger, two-time winner of the Nobel Prize and considered the "father of genomics", has died at the age of 95.

    Nov 20, 2013

  • Collins on the FDA Approval of Illumina's MiSeqDx

    Bio-IT World Roundup | Yesterday the FDA granted premarket clearance to Illumina's MiSeqDx platform as well as several diagnostic kits to go with the platform.

    Nov 20, 2013

  • Kansas Hospital Sequencing Infants

    Technology Review | Children’s Mercy Hospital in Kansas City has joined the ranks of pediatric hospitals actively using genome sequencing in their NICUs.

    Nov 19, 2013

  • Newest Top 500 Supercomputer List Released

    Computerworld | The Top 500 supercomputer list was released yesterday. Tianhe-2 in China still holds the top spot with Oak Ridge National Laboratories' Titan in the number 2 spot.

    Nov 19, 2013

  • The Short List: 2013's Biotech Startups

    Xconomy | Luke Timmerman calls this the "stingiest funding cycle for first-time biotech financings in almost two decades."

    Nov 18, 2013

  • Updates from Amazon Web Services

    Bio-IT World Roundup | Several new updates emerged from Amazon Web Services at the user conference last week including Kinesis and AppStream.

    Nov 18, 2013

  • UK Charity Launches Dementia Research Institute

    Bloomberg | Alzheimer's Research UK will fund a new drug discovery institute for dementia research.

    Nov 15, 2013

  • Sygnis Tackles Difficult DNA Amplification

    Bio-IT World News Brief | A new polymerase, PrimPol, joins previous Sygnis patent QualiPhi as the company establishes its niche in DNA amplification scenarios that the most commonly used polymerases have difficulty processing.

    Nov 15, 2013

  • NuMedii: From Off-Label to On-Target

    Wired | NuMedii has been hard at work finding alternative uses for existing drugs. Human trials have now commenced to use the antidepressant imipramine on small-cell lung cancer.

    Nov 14, 2013

  • Bacterial Toxins Suggest New Antibiotic Targets

    Molecular Cell | Michael Laub's lab at MIT is examining a bacterium's own toxin-antitoxin systems for clues to the development of novel antibiotics.

    Nov 14, 2013

  • AWS Tears Down Private Clouds

    Computerworld | At the Amazon Web Services Reinvent conference, Andy Jassy spared nothing in his assessment of private clouds, saying they offer "none of the benefits" of public cloud offerings.

    Nov 14, 2013

  • Eli and Edythe Broad Invest Another $100M in Broad Institute

    Bio-IT World News Brief | American philanthropists and entrepreneurs Eli and Edythe Broad are investing an additional $100 million into the Broad Institute to launch a new decade of transformative work to harness recent biomedical discoveries to benefit patients.

    Nov 14, 2013

  • Myriad Releases Three New Tests

    Bio-IT World | Myriad Genetics got their fare share of press this summer when the Supreme Court ruled that Myriad’s gene patents were invalid. But in the past three months, the company has released three diagnostic and prognostic tests. Patent or no patent, they’ve been busy.

    Nov 13, 2013